Abstract:OBJECTIVE:Glycogen debranching enzyme (AGL) plays an important role in complete degradation of the glycogen, and has two independent catalytic activities, i.e., those of alpha-1, 4-glucanotransferase (EC 2.4. 1.25) and amylo-1,6-glucosidase (EC 3.2. 1.33). A deficiency in activities of AGL causes excessive accumulation of glycogen with short branched outer chains and results in glycogen storage disease type III (GSD III; MIM #232 400), an autosomal recessive inborn disorder of glycogen metabolism. The present study aimed to investigate the mutation of AGL in 10 Chinese patients with GSD III.METHOD:Clinical and laboratory data of 10 patients with typical clinical manifestations of GSD III suggesting hypoglycemia, hyperlipidemia, increased creatine-phosphokinase and its isozyme were collected. The coding regions and their flanking introns of AGL gene of the 10 patients were amplified by PCR and analyzed by direct DNA sequencing. All the mutated alleles were confirmed by bidirectional DNA sequencing. The 3 novel splicing mutations were analyzed by restriction fragment length polymorphism (RFLP) in 50 healthy children (control). The 2 small deletions (c.408-411delTTTG, c.2717-2721delAGATC) were analyzed by fluorescent polymerase chain reaction and gene scan analysis to confirm the number of deleted bases.RESULT:Thirteen different mutations were identified, including 4 splicing mutations (IVS6 + 1G > A, IVS6-1G > A, IVS14 + 1G > T, IVS26-2A > C), 5 nonsense mutations (R469X, R864X, S929X, R977X, Y1428X), 3 small deletions (c.408-411delTTTG, c.2717-2721delAGATC, c.2823delT) and 1 insert mutation (c.4234insT). Except for IVS14 + 1G > T, R864X, and R977X, the other 10 mutations are novel; 18 mutated alleles were identified in the 20 alleles (90%). IVS14 + 1G > T was the most frequently seen mutation, accounting for 5 of 20 (25%) alleles examined. None of homozygote and heterozygote of the 3 novel splicing mutations was found in the 50 healthy controls by RFLP analysis. With the fluorescent polymerase chain reaction and gene scan analysis, c.408411deTTTG mutation and c.2717-2721delAGATC mutation were confirmed to have 4 and 5 bases deletion respectively.CONCLUSION:Thirteen mutations were identified in the 10 cases with GSD III, with 10 novel mutations. IVS14 + 1G > T was a relatively common mutation. This study revealed the heterozygosity of AGL gene in Chinese patients with GSD III.

Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases

Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX

Clinical features and PHKG2 gene mutation analysis of 5 Chinese patients with glycogen storage disease Ⅸc

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia

Clinical and genomic study of the infant with glycogen storage disease typeⅡ

Diagnosis and Follow‐up of Glycogen Storage Disease (GSD) Type VI from the Largest GSD Center in China

Molecular Diagnosis of Panel-Based Next-Generation Sequencing Approach and Clinical Symptoms in Patients with Glycogen Storage Disease: A Single Center Retrospective Study

Molecular Genetic Analysis of 10 Chinese Patients with Glycogen Storage Disease Type Iii

Glycogen Storage Disease Type VI Can Progress to Cirrhosis: Ten Chinese Patients with GSD VI and a Literature Review

Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review.

Genetic Analysis and Clinical Assessment of Four Patients with Glycogen Storage Disease Type IIIa in China

Gene mutation and clinical study in the patients with glycogen storage disease type Ⅰ a

A novel PHKA2 variant in a Chinese boy with glycogen storage diseases type IXa

Expanding the clinicopathological-genetic spectrum of glycogen storage disease type IXd by a Chinese neuromuscular center

Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].

Clinical and genetic features of patients with glycogen storage disease type Ⅸa:An analysis of 20 cases

The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III

Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa

The Clinical and Genetic Analysis of Glycogen Storage Disease Type IV in 5 Cases

Report of 7 cases of glycogen storage disease type VI and type IXa